David Rawlings
Pediatric Allergy/Immunology · Seattle, WANPI 1720164403
Payments from drug & device makers
$15,594,764in general payments, 2019–2025
Across 69 payments — averaging $226,011 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$15.5M
- Bayer$50K
- Spark Therapeutics, Inc.$8K
What the payments were for
- Consulting fees$25,51488%
- Travel & lodging$3,20111%
- Food & beverage$3151%
General payments by program year
19
20
21
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 59 | $15,537,220 |
| Bayer | 1 | $50,000 |
| Spark Therapeutics, Inc. | 9 | $7,544 |
How this compares
Too few pediatric allergy/immunology providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Other pediatric allergy/immunology in Seattle
- Maria Teresa de la MorenaSeattle$57K
- Hans OchsSeattle$23K
- Lauren GundermanSeattle$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.